BIO-TECHNE Corp 8-K

What Happened

• Bio-Techne Corporation (TECH) filed an 8-K on February 4, 2026 attaching press releases reporting its results of operations for the quarter and six months ended December 31, 2025 and its financial condition as of December 31, 2025. The filing also announced a cash dividend. The earnings and dividend announcements are included as Exhibits 99.1 and 99.2 to the filing. The report was signed by Shane V. Bohnen, Senior Vice President, General Counsel and Secretary.

Key Details

• Filing date: February 4, 2026; reporting period: quarter and six months ended December 31, 2025.
• Press release with results: Exhibit 99.1; press release announcing the cash dividend: Exhibit 99.2.
• The 8-K states the attached information is not “filed” for purposes of Section 18 of the Exchange Act and is not automatically incorporated by reference into other filings.
• Authorized signatory: Shane V. Bohnen, SVP, General Counsel & Secretary.

Why It Matters

• Earnings and financial-condition press releases can move the stock price and inform investors about recent operational performance (revenue, profit, cash flow) — investors should review Exhibit 99.1 for the specific results.
• The announced cash dividend (see Exhibit 99.2) signals management’s decision to return cash to shareholders; shareholders should check the press release for dividend amount, record and payment dates.
• This 8-K does not itself provide the numeric financial details in the filing text — retail investors should read the attached press releases for the actual revenue, earnings, and dividend figures before making investment decisions.